GPC1 and breast cancer: When considering the combined GPC1 Exo‐mRNA/tMV‐mProtein expression as was performed for PDAC, the ILN biochip assay was not able to effectively discriminate patients with HCC (Figure 6C), EC (Figure 6D), and BC (Figure 6E) from healthy donors.